Bioequivalence

• Relative Bioavailability

• Comparison between a test and reference drug product

  • commercial formulation vs. clinical trial material
  • generic drug vs. reference listed drug
  • drug product changed after approval vs. drug product before change

Previous slide

Next slide

Back to first slide

View graphic version